Back to Search Start Over

The two-stage placental model of preeclampsia: An update.

Authors :
Staff, Anne Cathrine
Source :
Journal of Reproductive Immunology. Sep2019, Vol. 134, p1-10. 10p.
Publication Year :
2019

Abstract

• Early-onset preeclampsia with poor placentation fitted well with the original two-stage model. • A revised model suggests a late form of placental malperfusion fitting with late-onset disease. • Major immunological preeclampsia findings are summarized and fit with the updated model. • "Maternal" preeclampsia does not exist, as all preeclampsia requires a placenta. Early-onset preeclampsia has been linked to poor placentation and fetal growth restriction, whereas late-onset preeclampsia was suggested to result from maternal factors. We have proposed an alternative model, suggesting that both early- and late-onset preeclampsia result from placental syncytiotrophoblast stress. This stress represents a common endpoint of several Stage 1 processes, promoting the clinical stage 2 of preeclampsia (new-onset hypertension and proteinuria or other signs of end-organ dysfunction), but the causes and timing of placental malperfusion differ. We have suggested that late-onset preeclampsia, without evidence of poor spiral artery remodelling, may be secondary to intraplacental (intervillous) malperfusion due to mechanical restrictions. As the growing placenta reaches its size limit, malperfusion and hypoxia occurs. This latter pathway reflects what is observed in postmature or multiple pregnancies. Our revised two-stage model accommodates most risk factors for preeclampsia including primiparity, chronic pre-pregnancy disease (e.g. obesity, diabetic-, chronic hypertensive-, and some autoimmune diseases), and pregnancy risk factors (e.g. multiple or molar pregnancies, gestational diabetes or hypertension, and low circulating Placental Growth Factor). These factors may increase the risk of progressing to the second stage of preeclampsia (both early- and late-onset) by affecting one of or both pathways leading to Stage 1, as well as potentially accelerating the steps towards Stage 2, including priming the maternal cardiovascular susceptibility to inflammatory factors shed by the placenta. This paper reviews previous preeclampsia findings and concepts, which fit with the revised two-stage model, and argues that "maternal" preeclampsia does not exist, as all preeclampsia requires a placenta. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01650378
Volume :
134
Database :
Academic Search Index
Journal :
Journal of Reproductive Immunology
Publication Type :
Academic Journal
Accession number :
138253033
Full Text :
https://doi.org/10.1016/j.jri.2019.07.004